Documents
Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;INTRATHECAL | 12MG/5ML (2.4MG/ML) | 1 | SPINRAZA | NUSINERSEN SODIUM |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2016-12-23 | PRIORITY |
LABELING; Labeling | SUPPL | 2 | AP | 2017-11-21 | STANDARD |
EFFICACY; Efficacy | SUPPL | 3 | AP | 2018-05-14 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2018-05-14 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2018-10-10 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2019-06-17 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2019-06-17 | STANDARD |
EFFICACY; Efficacy | SUPPL | 10 | AP | 2020-06-16 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 2 |
SUPPL | 2 | Null | 7 |
SUPPL | 3 | Null | 31 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 6 |
SUPPL | 7 | Null | 31 |
SUPPL | 8 | Null | 6 |
SUPPL | 10 | Null | 7 |
CDER Filings
BIOGEN IDEC
cder:Array
(
[0] => Array
(
[ApplNo] => 209531
[companyName] => BIOGEN IDEC
[docInserts] => ["",""]
[products] => [{"drugName":"SPINRAZA","activeIngredients":"NUSINERSEN SODIUM","strength":"EQ 12MG BASE\/5ML (EQ 2.4MG BASE\/ML)","dosageForm":"SOLUTION;INTRATHECAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"06\/16\/2020","submission":"SUPPL-10","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209531s010lbl.pdf\"}]","notes":""},{"actionDate":"06\/17\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209531s007s008lbl.pdf\"}]","notes":""},{"actionDate":"06\/17\/2019","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209531s007s008lbl.pdf\"}]","notes":""},{"actionDate":"10\/10\/2018","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s005lbl.pdf\"}]","notes":""},{"actionDate":"05\/14\/2018","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s003s004lbl.pdf\"}]","notes":""},{"actionDate":"05\/14\/2018","submission":"SUPPL-3","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s003s004lbl.pdf\"}]","notes":""},{"actionDate":"11\/21\/2017","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/209531s002lbl.pdf\"}]","notes":""},{"actionDate":"12\/23\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/209531lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"12\/23\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/209531lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/209531Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/209531Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"06\/16\/2020","submission":"SUPPL-10","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209531s010lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/209531Orig1s010ltr.pdf\"}]","notes":">"},{"actionDate":"06\/17\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209531s007s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/209531Orig1s007s008ltr.pdf\"}]","notes":">"},{"actionDate":"06\/17\/2019","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/209531s007s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/209531Orig1s007s008ltr.pdf\"}]","notes":">"},{"actionDate":"10\/10\/2018","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209531Orig1s005Ltr.pdf\"}]","notes":">"},{"actionDate":"05\/14\/2018","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s003s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209531Orig1s003s004ltr.pdf\"}]","notes":">"},{"actionDate":"05\/14\/2018","submission":"SUPPL-3","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/209531s003s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/209531Orig1s003s004ltr.pdf\"}]","notes":">"},{"actionDate":"11\/21\/2017","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/209531s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/209531Orig1s002ltr.pdf\"}]","notes":">"}]
[actionDate] => 2020-06-16
)
)